Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study (Q44709399)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study |
scientific article |
Statements
1 reference
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study (English)
1 reference
Grace A McComsey
1 reference
Douglas J Ward
1 reference
Siegrid M Hessenthaler
1 reference
Michael G Sension
1 reference
Peter Shalit
1 reference
J Tyler Lonergan
1 reference
Robin L Fisher
1 reference
Vanessa C Williams
1 reference
Jaime E Hernandez
1 reference
Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Positive Subjects (TARHEEL; ESS40010) Study Team
1 reference
18 December 2003
1 reference
1 reference
Identifiers
1 reference